COVID-19疫苗认知态度量表的效度和信度

Hüseyin Eriş
{"title":"COVID-19疫苗认知态度量表的效度和信度","authors":"Hüseyin Eriş","doi":"10.46648/gnj.379","DOIUrl":null,"url":null,"abstract":"A virus detected in Wuhan, China on December 29, 2019, was named covid-19 and declared a pandemic by the world health organization on March 11, 2020, due to the destruction caused by this virus.Due to the lack of any treatment method for the new virus, many countries and pharmaceutical companies have started to develop vaccines against this virus. Although rapidly developed vaccines have been put into practice worldwide, some individuals objected to being vaccinated for reasons such as vaccine hesitancy or anti-vaccination. Some of the individuals in Turkey are also indecisive about vaccines and therefore do not want to be vaccinated. The purpose of this research is to develop a scale with proven validity and reliability to measure the perceptions and attitudes of individuals aged 18 and over living in Turkey towards Covid-19 vaccines. For this purpose, the covid-19 vaccine perception and attitude scale, which consists of 21 expressions and 2 sub-dimensions, was transferred to the electronic environment and applied to 291 people in Turkey between 15.09.2021 and 16.09.2021. The reliability values of both sub-dimensions of the scale used in the research were high. According to the Bartlett test performed, it is appropriate and necessary to perform factor analysis on the items in the scale, the sample size is sufficient in terms of representing the universe in the research for factor analysis of the KMO coefficient, and the high factor loads of the items in the scale show that it is important for the scale to which the items belong. As a result, it has been determined that this developed scale is a valid measurement tool to determine the covid-19 vaccine perceptions and attitudes of people aged 18 and over, according to the results of the analysis, and its reliability is also high.","PeriodicalId":394509,"journal":{"name":"Gevher Nesibe Journal IESDR","volume":"98 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Validity And Reliability Of The COVID-19 Vaccine Perception And Attitude Scale\",\"authors\":\"Hüseyin Eriş\",\"doi\":\"10.46648/gnj.379\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A virus detected in Wuhan, China on December 29, 2019, was named covid-19 and declared a pandemic by the world health organization on March 11, 2020, due to the destruction caused by this virus.Due to the lack of any treatment method for the new virus, many countries and pharmaceutical companies have started to develop vaccines against this virus. Although rapidly developed vaccines have been put into practice worldwide, some individuals objected to being vaccinated for reasons such as vaccine hesitancy or anti-vaccination. Some of the individuals in Turkey are also indecisive about vaccines and therefore do not want to be vaccinated. The purpose of this research is to develop a scale with proven validity and reliability to measure the perceptions and attitudes of individuals aged 18 and over living in Turkey towards Covid-19 vaccines. For this purpose, the covid-19 vaccine perception and attitude scale, which consists of 21 expressions and 2 sub-dimensions, was transferred to the electronic environment and applied to 291 people in Turkey between 15.09.2021 and 16.09.2021. The reliability values of both sub-dimensions of the scale used in the research were high. According to the Bartlett test performed, it is appropriate and necessary to perform factor analysis on the items in the scale, the sample size is sufficient in terms of representing the universe in the research for factor analysis of the KMO coefficient, and the high factor loads of the items in the scale show that it is important for the scale to which the items belong. As a result, it has been determined that this developed scale is a valid measurement tool to determine the covid-19 vaccine perceptions and attitudes of people aged 18 and over, according to the results of the analysis, and its reliability is also high.\",\"PeriodicalId\":394509,\"journal\":{\"name\":\"Gevher Nesibe Journal IESDR\",\"volume\":\"98 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gevher Nesibe Journal IESDR\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46648/gnj.379\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gevher Nesibe Journal IESDR","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46648/gnj.379","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

2019年12月29日在中国武汉发现的一种病毒,由于其造成的破坏,于2020年3月11日被世界卫生组织命名为covid-19,并宣布为大流行。由于缺乏针对这种新病毒的任何治疗方法,许多国家和制药公司已开始开发针对这种病毒的疫苗。尽管快速开发的疫苗已在世界范围内投入使用,但有些人因疫苗犹豫或反疫苗接种等原因反对接种疫苗。土耳其的一些人对疫苗也犹豫不决,因此不想接种疫苗。本研究的目的是开发一种经过验证的有效性和可靠性量表,以衡量居住在土耳其的18岁及以上个人对Covid-19疫苗的看法和态度。为此,将包含21个表达和2个子维度的covid-19疫苗感知和态度量表转移到电子环境中,并于2021年9月15日至2021年9月16日在土耳其对291人进行了应用。本研究所用量表的两个子维度的信度值均较高。根据Bartlett检验,对量表中的条目进行因子分析是适当和必要的,在KMO系数因子分析研究中,样本量足以代表整个宇宙,量表中条目的高因子负荷表明对条目所属的量表很重要。因此,根据分析结果,确定该量表是确定18岁及以上人群对covid-19疫苗认知和态度的有效测量工具,其可靠性也很高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Validity And Reliability Of The COVID-19 Vaccine Perception And Attitude Scale
A virus detected in Wuhan, China on December 29, 2019, was named covid-19 and declared a pandemic by the world health organization on March 11, 2020, due to the destruction caused by this virus.Due to the lack of any treatment method for the new virus, many countries and pharmaceutical companies have started to develop vaccines against this virus. Although rapidly developed vaccines have been put into practice worldwide, some individuals objected to being vaccinated for reasons such as vaccine hesitancy or anti-vaccination. Some of the individuals in Turkey are also indecisive about vaccines and therefore do not want to be vaccinated. The purpose of this research is to develop a scale with proven validity and reliability to measure the perceptions and attitudes of individuals aged 18 and over living in Turkey towards Covid-19 vaccines. For this purpose, the covid-19 vaccine perception and attitude scale, which consists of 21 expressions and 2 sub-dimensions, was transferred to the electronic environment and applied to 291 people in Turkey between 15.09.2021 and 16.09.2021. The reliability values of both sub-dimensions of the scale used in the research were high. According to the Bartlett test performed, it is appropriate and necessary to perform factor analysis on the items in the scale, the sample size is sufficient in terms of representing the universe in the research for factor analysis of the KMO coefficient, and the high factor loads of the items in the scale show that it is important for the scale to which the items belong. As a result, it has been determined that this developed scale is a valid measurement tool to determine the covid-19 vaccine perceptions and attitudes of people aged 18 and over, according to the results of the analysis, and its reliability is also high.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信